BA
Boyer Andrew S
Vice-Président Exécutif
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Boyer Andrew S, Vice-Président Exécutif. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. In total, 22 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €1.6m. History available since 3 March 2023. The latest transaction was disclosed on 21 August 2026 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Boyer Andrew S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
152,426 股0Class A Common StockSEC:0001628280-26-058918:0
39,252 股Class A Common StockSEC:0001628280-26-015238:0
175,000 股@ US$2.7520.4% 占其流量Class A Common StockSEC:0001628280-25-041033:0
33,436 股@ US$9.0516.1% 占其流量Class A Common StockSEC:0001723128-25-000048:0
125,000 股@ US$8.8977.4% 占其流量Class A Common StockSEC:0001628280-25-011310:0
39,251 股Class A Common StockSEC:0001628280-25-010718:0
31,371 股Class A Common StockSEC:0001628280-25-010118:0
22,486 股@ US$7.8111.8% 占其流量Class A Common StockSEC:0001628280-24-037559:0
31,371 股Class A Common StockSEC:0001628280-24-008951:0
31,663 股Class A Common StockSEC:0001628280-24-007998:0
29,302 股@ US$4.12678.2% 占其流量Class A Common StockSEC:0001209191-23-045846:0
23,095 股Class A Common StockSEC:0001209191-23-041087:0
19,685 股@ US$1.922.6% 占其流量Class A Common StockSEC:0001209191-23-016929:1
39,251 股Class A Common StockSEC:0001209191-23-016929:0
12,346 股Class A Common StockSEC:0001209191-23-015521:0
31,662 股Class A Common StockSEC:0001209191-23-014118:0
23,094 股Class A Common StockSEC:0001209191-22-040624:0
16,656 股Class A Common StockSEC:0001209191-22-028154:0
12,346 股Class A Common StockSEC:0001209191-22-016047:0
31,662 股Class A Common StockSEC:0001209191-22-014133:0
23,095 股Class A Common StockSEC:0001209191-21-044367:0
16,655 股Class A Common StockSEC:0001209191-21-031565:0
About Boyer Andrew S
BOYER ANDREW S is Vice-Président Exécutif and is linked to Amneal Pharmaceuticals, Inc. (XNAS) as Executive Vice President. He has 21 filings in total, and across the recent sampled filings from 2021-05-11 to 2026-03-05, the reported volume is EUR 0 on the buy side and EUR 1574394 on the sell side, with the dominant transaction nature indicated as Levée d'options.